Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Raw Materials: 2024

Historic Raw Materials for Iovance Biotherapeutics (IOVA) over the last 1 years, with Dec 2024 value amounting to $27.7 million.

  • Iovance Biotherapeutics' Raw Materials rose 581.14% to $37.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $37.9 million, marking a year-over-year increase of 581.14%. This contributed to the annual value of $27.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Raw Materials of $27.7 million as of FY2024.
  • Iovance Biotherapeutics' 5-year Raw Materials high stood at $27.7 million for FY2024, and its period low was $27.7 million during FY2024.
  • Its 1-year average for Raw Materials is $27.7 million, with a median of $27.7 million in 2024.